FDA NDC Directory · JSON-LD · Markdown

Fosaprepitant

NDC 0591-4385 · HUMAN PRESCRIPTION DRUG · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Generic namefosaprepitant
Labeler / ManufacturerActavis Pharma, Inc.
Marketing categoryNew Drug Application (innovator) · App NDA210064
Dosage form / routeINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · INTRAVENOUS
Active ingredientsFOSAPREPITANT DIMEGLUMINE (150 mg/1)
Marketing started20190919
Package count1

External sources

Source: openFDA. Public-domain (CC0).